BRCA1 and ovarian carcinoma: Screening for specific BRCA1/2 mutations that occur at high frequency in certain populations not only help in better clinical management of breast and ovarian cancers but can also be an invaluable tool in identifying healthy individuals who are currently disease-free but are at an increased risk of developing breast and/or ovarian cancer later in life (13).